SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope

JCI Insight - Combined anti-S1 and anti-S2 antibodies from hybrid

Frontiers Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study

SARS-CoV-2 variants, spike mutations and immune escape

Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants – ScienceOpen

Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein driving the genesis of Omicron variants

Frontiers Inducing enhanced neutralizing antibodies against

Selection for immune evasion in SARS-CoV-2 revealed by high

Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody

SARS-CoV-2 Delta and Omicron variants evade population antibody

Frontiers Multiple SARS-CoV-2 Variants Exhibit Variable Target

Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human

Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques - ScienceDirect

SARS-CoV-2 Delta and Omicron variants evade population antibody